Skip to main

Resources

Displaying 10 of 271 results

AST welcomes Drs. Lentine, Hussain, Garg, and panelists Dr. McNatt, Mr. Howey, and Ms. Tietjen, to discuss managing the costs of kidney paired donation (KPD).

Hosted by the AST Transplant Pharmacy Community of Practice (TxPharm COP) and Liver and Intestinal Community of Practice (LICOP).

This KPCOP manuscript was published in Current Opinion in Nephrology and Hypertension on October 27, 2026.

The Liver Meeting® (TLM) experience goes beyond the sessions. ELEVATE your experience by connecting with the liver community, engaging with AASLD and AASLD Foundation, discovering new ways to learn, participate, and shape our community.

AST welcomes Drs. Kizilbash, Valencia Deray, and Ouellette to discuss the effect of pre-emptive rituximab on EBV DNA levels and prevention of post-transplant lymphoproliferative disorder in pediatric kidney transplant recipients.

AST welcomes Drs. King, Olthoff, and Kappus, to discuss living liver donation in North America and mortality associated with donation.

The American Society of Nephrology created a library of resources to help the transplant community better prepare for emergencies.

A patient guide to financial assistance programs and savings resources that can help reduce the cost of transplant medications. Created by the Transplant Pharmacy Community of Practice.

Developed for healthcare providers caring for pediatric transplant patients under 18, this Vaccine Roadmap provides a comprehensive vaccination schedule developed through a multidisciplinary PCOP collaboration.

ATW 2026 is the international congress of the Korean Society for Transplantation. Since its inception in 2016, it has grown into one of Asia's leading academic meetings in the field of transplantation.

Give Back

Make a difference in the field of transplantation by donating to support our cause.

Give

Sign up for AST eNews

This resource for transplant professionals shares AST news events and top articles in transplantation.

Advertisements

This content was developed independently by AST and supported by a financial contribution from Sanofi